Picture of RP Bio lnc logo

314140 RP Bio lnc Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m-4.89%
3m-21.73%
6m-5.55%
1yr-31.33%
Volume Change (%)
10d/3m-17.65%
Price vs... (%)
52w High-31.18%
50d MA-10.54%
200d MA-10.93%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value0.67
Price to Tang. Book0.67
Price to Free Cashflow17.43
Price to Sales0.46
EV to EBITDA6.98

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital5.4%
Return on Equity4.37%
Operating Margin3.95%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueKR₩m69,855.1697,922.65114,963.99138,109.32151,046.48203,700n/a21.26%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/a+42.98+14.31+40.61-23.07+220.74n/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of RP Bio lnc EPS forecast chart

Profile Summary

RP Bio lnc is a Korea-based company mainly engaged in the manufacture and sale of health functional foods and pharmaceuticals. The Company is engaged in the production and sale of health functional foods such as multi-vitamins, collagen, lactic acid bacteria, and aloe. In addition, the Company is engaged in the production and sale of medicines such as cold medicines, painkillers, dementia prevention medicines, acne treatment medicines, and sleep improvement medicines.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    March 31st, 2024
    Incorporated
    August 5th, 2016
    Public Since
    September 29th, 2022
    No. of Shareholders
    15,543
    No. of Employees
    548
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    kr flag iconKorea Exchange - KOSDAQ
    Shares in Issue
    8,649,842

    314140 Share Price Performance

    Upcoming Events for 314140

    Similar to 314140

    Picture of AbClon logo

    AbClon

    kr flag iconKorea Exchange - KOSDAQ

    Picture of ADBiotech Co logo

    ADBiotech Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Ahn-Gook Pharmaceutical Co logo

    Ahn-Gook Pharmaceutical Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Alteogen logo

    Alteogen

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Aminologics Co logo

    Aminologics Co

    kr flag iconKorea Exchange - KOSDAQ

    FAQ